ASND ▲ +1.3% - Ascendis Pharma A/S $ASND - Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases Ascendis Pharma rose 1.3% after announcing it will regain rights to its TransCon® technology platform in the metabolic and cardiovascular disease areas. The recovery of control over the technology in these therapeutic categories represents a significant expansion of the company's pipeline and proprietary asset base. 14-SEP-2026 06:00 PM ET